action of glp 1 GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes Recent updates on GLP-1 agonists:

People lost weight during the initial phase and continued to lose weight after they were on the target dosage of Semaglutide GLP-1

The GLP-1 and GLP-1/GIP medications liraglutide, semaglutide and tirzepatide are licensed for weight loss in the UK but only around 220,000 people will be eligible for treatment with these on the NHS between 2025 and 2028

These blood tests ensure the medication is safe for your body, help monitor your overall metabolic health, and confirm the treatment is having positive effects beyond the scale

These trials revealed that empagliflozin-treated patients with left ventricular ejection fraction 40% experienced a lower risk of cardiovascular death or hospitalization for heart failure regardless of the presence or absence of diabetes [26, 27]

Aim for a minimum of 64 ounces of water daily, more if you exercise or live in a hot climate